{"result": "(\"entity\"<|>HOMOCIGOSIS<|>EVENT<|>Homocigosis refers to the genetic condition where an individual has two identical alleles for a particular gene, which in this context relates to the risk of developing hereditary hemochromatosis.)\n##\n(\"entity\"<|>C282Y<|>PERSON<|>C282Y is a specific mutation associated with hereditary hemochromatosis, which can lead to iron overload in the body.)\n##\n(\"entity\"<|>FERRITINA<|>PERSON<|>Ferritina is a protein that stores iron in the body and is used as a marker to assess iron levels in patients.)\n##\n(\"entity\"<|>HEMOCHROMATOSIS<|>EVENT<|>Hemochromatosis is a condition characterized by excessive iron accumulation in the body, which can lead to serious health issues.)\n##\n(\"entity\"<|>ELECTROFISIOLOGÍA<|>EVENT<|>Electrofisiología is a medical specialty that studies the electrical properties of biological cells and tissues, often used in the context of diagnosing heart conditions.)\n##\n(\"entity\"<|>ANEMIA<|>EVENT<|>Anemia is a condition where there is a deficiency of red blood cells or hemoglobin in the blood, leading to fatigue and weakness.)\n##\n(\"entity\"<|>FLEBOTOMÍAS<|>EVENT<|>Flebotomías are medical procedures involving the withdrawal of blood from a patient, often used to treat conditions like hemochromatosis.)\n##\n(\"entity\"<|>RESONANCIA MAGNÉTICA<|>EVENT<|>Resonancia magnética is a non-invasive imaging technique used to diagnose various medical conditions, including liver iron overload.)\n##\n(\"entity\"<|>CARCINOMA HEPATOCELULAR<|>EVENT<|>Carcinoma hepatocelular is a type of liver cancer that can develop as a complication of chronic liver disease, including hemochromatosis.)\n##\n(\"entity\"<|>FIBROSIS HEPÁTICA<|>EVENT<|>Fibrosis hepática is the thickening and scarring of liver tissue, often resulting from chronic liver diseases such as hemochromatosis.)\n##\n(\"relationship\"<|>C282Y<|>HEMOCHROMATOSIS<|>C282Y mutation is a significant genetic factor that increases the risk of developing hemochromatosis<|>8)\n##\n(\"relationship\"<|>FERRITINA<|>HEMOCHROMATOSIS<|>Ferritina levels are monitored to assess the severity of iron overload in patients with hemochromatosis<|>7)\n##\n(\"relationship\"<|>FLEBOTOMÍAS<|>HEMOCHROMATOSIS<|>Flebotomías are a common treatment method for managing iron overload in patients with hemochromatosis<|>9)\n##\n(\"relationship\"<|>RESONANCIA MAGNÉTICA<|>HEMOCHROMATOSIS<|>Resonancia magnética is used to diagnose and monitor liver conditions, including hemochromatosis<|>6)\n##\n(\"relationship\"<|>CARCINOMA HEPATOCELULAR<|>HEMOCHROMATOSIS<|>Carcinoma hepatocelular can develop as a serious complication of untreated hemochromatosis<|>8)\n##\n(\"relationship\"<|>FIBROSIS HEPÁTICA<|>HEMOCHROMATOSIS<|>Fibrosis hepática is a potential outcome of chronic iron overload due to hemochromatosis<|>7)\n##\n(\"relationship\"<|>ANEMIA<|>HEMOCHROMATOSIS<|>Anemia can be associated with hemochromatosis, particularly if iron levels are not managed properly<|>5)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ría de 500 ml\ndos los hijos, ya que tienen un 50% de riesgo de here-                     semanalmente (equivalente a unos 250 mg de hierro)\ndar la mutación en homocigosis. Ante un paciente ho-                       hasta que la ferritina se mantenga entre 50-100 ng/\nmocigoto C282TY/C282Y y un cónyuge no portador se                          ml26, y el IST menor del 45%. Para ello, en el varón\n\npuede deducir que todos los hijos son portadores hete-                     suele ser necesario extraer unos 5 g de hierro y en la\nrocigotos (C282Y/normal ) no enfermos. Si el cónyuge                       mujer 3 g, aunque puede haber pacientes donde el\nes portador sano en heterocigosis (C282Y/normal) el                        acúmulo de hierro es mayor de 30 g La hemoglobina\n50% de los hijos serán homocigotos C282TY/C282Y,                           debe determinarse semanalmente, el IST y la ferritina\nteniendo un riesgo muy elevado de desarrollar la enfer-                    cada 2 o 3 meses. No todos los pacientes con HH rea-\nmedad (según penetrancia 70%) y por lo tanto será                          cumulan hierro de igual modo, por lo que la frecuencia\nnecesario determinar el IST y la ferritina sérica anual-                   de las flebotomías de mantenimiento varía en cada pa-\nmente. El otro 50% serán portadores sanos heteroci-                        ciente. En algunos casos se consigue con 2 o 3 anuales\ngotos (C282Y/normal ).                                                     en el varón y 1 o 2 en la mujer, y en otros es necesario\n   Para el cribado poblacional tiene menos valor el es-                    realizarlas mensualmente.\ntudio genético, dado que la penetrancia es incompleta                         Si el paciente no tolera el ritmo de las flebotomías,\n(70%), hay casos de HH hereditarias sin mutaciones                         estas se deben espaciar o disminuir a 250-300 ml, y si\ndetectables y además sería muy costoso. Por ello, en                       presenta anemia asociada se puede valorar el uso de\nprincipio se realizaría el IST y ferritina en varones a par-               eritropoyetina recombinante humana. En los niños se\ntir de los 30 años y en mujeres a los 40, identificando                    debe esperar hasta la edad adulta para realizar fleboto-\ncandidatos, en su mayoría asintomáticos, para poste-                       mías, excepto si la ferritina es mayor de 300 ng/ml. Y\nriormente valorar la realización de estudio genético.                      en el embarazo, si la ferritina está elevada, las fleboto-\n                                                                           mías deberían retrasarse hasta después de la gestación\n   Estudios de imagen: Resonancia magnética. Es el                         a menos que exista daño hepático o cardiaco significa-\nmejor método diagnóstico no invasivo debido a las                          tivo, en cuyo caso se deberá valorar el riesgo/beneficio\npropiedades paramagnéticas del hierro que permiten                         por parte de un especialista experimentado25.\ncuantificar la concentración de hierro hepático. Puede                        La realización de flebotomías es seguida de una me-\nconfirmar el diagnóstico, es capaz de distinguir entre la                  joría del dolor abdominal, de la astenia, de los requeri-\nHH primaria y las formas secundarias de sobrecarga                         mientos de insulina, de la hiperpigmentación de la piel,\nférrica, puede determinar la gravedad de la lesión y                       de la cardiopatía, de la supervivencia y de la fibrosis\nmonitorizar el efecto del tratamiento, con la ventaja                      hepática, que en algunos casos puede llegar a desapa-\nañadida de poder detectar lesiones neoplásicas peque-                      recer. Otras manifestaciones no mejoran, como la atro-\nñas hepáticas42. Además, aporta información sobre el                       fia testicular, la artropatía y la cirrosis avanzada. La rea-\ngrado de fibrosis, pero únicamente tiene utilidad en                       lización de flebotomías antes del desarrollo de fibrosis\neste aspecto cuando la biopsia hepática está contrain-                     avanzada es una estrategia importante para prevenir el\ndicada43.                                                                  carcinoma hepatocelular, ya que si el paciente ha desa-\n                                                                           rrollado cirrosis hepática tiene un riesgo aumentado de\n   Elastografía: Se ha introducido en los últimos años                     presentar dicha neoplasia, y debe someterse a progra-\ncomo un método no invasivo eficaz en la valoración de                      mas de vigilancia45. El carcinoma hepatocelular repre-\n---\n 420      BLOQUE: METABOLISMO\n\n\n\nsenta aproximadamente el 30% de las muertes relacio-               de otros alimentos. Sin embargo, no se debe abu-\nnadas con HH, mientras que las complicaciones de la\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}